Author

Khalid Omer Alfarouq

Zamzam University College, Khartoum, Sudan - Cited by 2,058 - Evolutionary Oncology - Tumor Metabolism - Molecular Pharmacology

Biography

Dr. Khalid Omer Alfarouk  currently works at Hala Alfarouk Cancer Center. Khalid does research in Cancer Research, Cell Biology and Clinical Pharmacology. Their current project is 'Curing cancer.' He has completed his education from University of Khartoum in Pharmacy. He has also worked at Moffitt Cancer Center in the Department of Integrated Mathematical Oncology, Tampa, United States. He has around 73 publications. His area of expertise are Cancer Biology,Ecology, Genetics, Cell Biology, Cell Culture.
Title
Cited by
Year
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
KO Alfarouk, CM Stock, S Taylor, M Walsh, AK Muddathir, D Verduzco, ...Cancer cell international 15 (1), 1-13, 2015201
544
2015
The Warburg effect and the hallmarks of cancer
L Schwartz, C T Supuran, K O AlfaroukAnti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017201
290
2017
Out of Warburg Effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH
L Schwartz, T Seyfried, KO Alfarouk, JDV Moreira, S FaisSeminars in Cancer Biology, 2017201
108
2017
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
KO Alfarouk, AHH Bashir, AN Aljarbou, AMA Ramadan, AK Muddathir, ...Frontiers in Oncology 9, 75, 2019201
87
2019
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
KO AlfaroukJournal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 859-866, 2016201
77
2016
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
KO Alfarouk, SBM Ahmed, RL Elliott, B A, SS Alqahtani, ME Ibrahim, ...Metabolites 10 (285), 2020202
71
2020
Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases
S Harguindey, D Stanciu, J Devesa, K Alfarouk, RA Cardone, JDP Orozco, ...Seminars in Cancer Biology 43, 157-179, 2017201
54
2017
The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
KO Alfarouk, SBM Ahmed, A Ahmed, RL Elliott, ME Ibrahim, HS Ali, ...Cancers 12 (4), 898, 2020202
36
2020
Doxycycline as Potential Anti-Cancer Agent
I Ali, KO Alfarouk, SJ Reshkin, ME IbrahimAnti-Cancer Agents in Medicinal Chemistry, 2017201
28
2017
The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela
RA Cardone, KO Alfarouk, RL Elliott, SS Alqahtani, SM Babikir, ...International Journal of Molecular Sciences 20 (15), 3694, 2019201
28
2019
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
TMA Carvalho, D Di Molfetta, MR Greco, T Koltai, KO Alfarouk, ...Cancers 13 (23), 6135, 2021202
24
2021
Of mitochondrion and COVID-19
KO Alfarouk, STS Alhoufie, A Hifny, L Schwartz, AS Alqahtani, ...Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1258-1267, 212
20
2021
Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies
S Harguindey, JP Orozco, KO Alfarouk, J DevesaInternational Journal of Molecular Sciences 20 (17), 4278, 2019201
15
2019
Drug Development: Stages of Drug Development
GO Elhassa, KO AlfaroukJournal of Pharmacovigilance 3 (3), 2015201
14
2015
Pathogenesis and Management of COVID-19
KO Alfarouk, AH STS, A SBM, S M, A A, A SS, A AS, A AM, R AM, A ME, ...Journal of Xenobiotics 11 (2), 77-93, 2021202
14
2021
Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways
SH Suleiman, ME Koko, WH Nasir, O Elfateh, UK Elgizouli, MOE Abdallah, ...Frontiers in genetics 6, 288, 2015201
13
2015
Correlation between the body mass index and psoriasis in dermatology and venereology teaching hospital in Khartoum
HE Elobeid, KO Alfarouk, AN Aljarbou, GO Elhassan, AK Muddathir, ...AJDV 6 (2), 30-9, 2017201
12
2017
A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
S Harguindey, K Alfarouk, JP Orozco, K Hardonniere, D Stanciu, S Fais, ...International Journal of Molecular Sciences 21 (3), 11, 2020202
10
2020
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
T Kolti, SJ Reshkin, C TMA, D DiMolfetta, MR Greco, KO Alfarouk, ...Cancers 14 (10), 246, 2022202
8
2022
Metabolic Shifts as the Hallmark of Most Common Diseases: The Quest for the Underlying Unity
L Schwartz, M Henry, KO Alfarouk, SJ Reshkin, R MInternational Journal of Molecular Sciences 22 (8), 392, 2021202
7
2021

Referred From: https://scholar.google.com/citations?user=AOa_39QAAAAJ&hl=en

Cited by
Citations 2058
h-index 17
i10-index 23
Recommended Journals
Open Access Journals